Effect of neoadjuvant chemotherapy on estrogen receptor, progesterone receptor, Cerb-B-2, vascular endothelial growth factor and Ki-67 in patients with locally advanced breast cancer

SARITAŞ, AHMET; YALAV, ORÇUN; Kekec, Yalcin; SAKMAN, GÜRHAN; BAĞIR KILIÇ, EMİNE; ZORLUDEMİR, SUZAN; ERGİN, MELEK; Eray, Tsmail; Kara, Tsmail; PAYDAŞ, SEMRA

doi:10.17826/cumj.412192

Effect of neoadjuvant chemotherapy on estrogen receptor, progesterone receptor, Cerb-B-2, vascular endothelial growth factor and Ki-67 in patients with locally advanced breast cancer

Atıf İçin Kopyala

SARITAŞ A. G., YALAV O., Kekec Y., SAKMAN G., BAĞIR KILIÇ E., ZORLUDEMİR S., ...Daha Fazla

CUKUROVA MEDICAL JOURNAL, cilt.44, sa.1, ss.226-231, 2019 (ESCI)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 44 Sayı: 1
Basım Tarihi: 2019
Doi Numarası: 10.17826/cumj.412192
Dergi Adı: CUKUROVA MEDICAL JOURNAL
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.226-231
Çukurova Üniversitesi Adresli: Evet

Özet

Purpose: The aim of this study is aimed to demonstrate the changes in the tumor diameter and expressions of vascular endothelial growth factor (VEGF), estrogen receptor (ER), progesterone receptor (PR), Ki-67, and Cerb-B2 status after neoadjuvant chemotherapy in the patients with locally advanced breast cancer.